Vanguard founder and former CEO John Bogle told CNBC that he expects the stock market's meager returns to continue for some time. "Be mentally prepared for some pretty slovenly going--some subdued returns--for quite a few years," Bogle said.
This morning, Bear Stearns biotech analyst Mark Schoenebaum and a couple of members of his research team hosted a conference call with a 50-page PowerPoint about Amgen. The purpose was to drill down into the looming court decision over whether Roche will be able to launch a competing anemia drug in the U.S. for kidney dialysis patients.
Big pharma CEOs might wanna watch their backs because there could be a burgeoning power struggle in the C-suite. Ernst & Young, which has a long history of doing comprehensive reports on the pharmaceutical and biotech industries, is out with a new one today declaring that it's big pharma Chief Financial Officers who have all the mojo these days.
Government favor of the corn-based alternative fuel was a big mistake, he says. Here's how to avoid repeating it.
As proxy statements pop up on www.sec.gov, investors can get a peek at who's making what. When you go to the web site, click on "Search for company filings," then click on "Companies and other filers," enter the ticker symbol, click on "Find companies" and then open up the "14A" or proxy statement.
With CEO Jim Sinegal predicting the company will double its size in ten years, it's no surprise Cramer said this is "the best retailer in America."
Shares of Canada's biggest biotech initially hit a new intra-day low this morning of 10 bucks a share this morning, but rallied into the close as investors seem to like the fact that the company may have extricated itself from allegations of financial fraud.
Electronic Arts said Monday that Chief Financial Officer Warren Jenson will leave the video game publisher, which is pursuing a hostile takeover of rival Take-Two Interactive Software.
The U.S. Securities and Exchange Commission charged Canada's Biovail, two current senior executives and former Chief Executive Eugene Melnyk with engaging in a number of fraudulent accounting schemes, the agency said on Monday.
Mojo, Buzz. You pick the adjective. The auto industry is lacking the one car, truck, or SUV that everyone is talking about. You know, the one model getting attention, good or bad. Think Hummer from 5 years ago. Or the Prius 3 years ago.
A bank known for having the smartest guys making the smartest investments has fallen from grace.
The backlash from the Icy Hot recall isn’t done playing out, he says.
The tax play has regained its footing and is now crushing the competition. Find out why Cramer thinks this is just the beginning.
As I sat down to interview Chrysler CEO Bob Nardelli, Co-President Jim Press, and Co-President Tom LaSorda two things jumped out in my mind. First: is Chrysler's turn-around on target? Second: Do Chrysler's growth plans remove lingering doubts about the automaker's future.
Warren Buffett's performance vs. pay ratio, already enormous by Corporate America's standards, got even more impressive in 2007. In a SEC filing ahead of Berkshire Hathaway's annual meeting in early May, the company lists an annual salary of $100,000 for its Chairman and CEO.
So says the CEO in an interview with Cramer. Find out why.
Shareholders want Michael Ward out. The question is, why? Is being near the top of the S&P 500 not enough for them?
This St. Patrick's Day morning several analysts are out with their official takes on Genentech's investor meeting last Friday and of the half dozen or so I've seen so far, I'd say the reaction is definitely mixed. I also wanted to throw in a few more notable quotables from CEO Art Levinson at the Friday presentation.
From harsh criticism of the Federal Reserve in the United States to the MIPIM real estate conference in Cannes, the week was filled with compelling video. But only seven made the cut.
Three days before announcing that Bear Stearns' financial situation had substantially worsenend, chief executive Alan Schwartz told CNBC he is not aware of any imminent threat to the Wall Street investment bank's liquidity.